Highlight• Calcium build-up in the coronary artery walls was more useful for correctly predicting kidney disease patients’ risk of heart disease than other measures of atherosclerosis such as thickness of the carotid artery walls and narrowing of the arteries in the legs.

60 million people globally have chronic kidney disease.

Newswise — Washington, DC (August 21, 2014) — Calcium buildup in the coronary arteries may be a better indicator of kidney disease patients’ risk of heart disease than traditional risk factors used in the general population, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings provide valuable new information that could help safeguard the heart health of patients with kidney disease.

Heart disease is the leading cause of death in individuals with chronic kidney disease (CKD). Some studies have found that conventional risk factors for predicting an individual’s likelihood of developing heart disease aren’t as useful in CKD patients as they are in the general population.

Kunihiro Matsushita, MD, PhD (Johns Hopkins Bloomberg School of Public Health) and his colleagues looked to see if calcium measurements within blood vessel walls might be helpful. Because the kidney helps regulate the body’s calcium levels, individuals with chronic kidney disease often have altered calcium metabolism, which may influence the usefulness of calcium in the coronary artery walls as an indicator of heart disease.

The researchers studied 6553 adults aged 45 to 84 years who did not have prior cardiovascular disease and who were participating in the Multi-Ethnic Study of Atherosclerosis. Among the participants, 1284 had CKD.

During a median follow-up of 8.4 years, 650 cardiovascular events (coronary heart disease, stroke, heart failure, and peripheral artery disease) occurred, with 236 of the events occurring in participants with CKD. The investigators found that calcium build-up in the coronary artery walls was more useful for correctly determining CKD patients’ risk of cardiovascular disease (particularly coronary heart disease and heart failure) than other measures of atherosclerosis such as thickness of the carotid artery walls and narrowing of the arteries in the legs.

“Our research is important since it assures the usefulness of coronary artery calcium for better cardiovascular disease prediction in persons with CKD, a population at high risk for cardiovascular disease but with potential caveats for the use of traditional risk factors,” said Dr. Matsushita.

Study co-authors include Yingying Sang, MS, Shoshana Ballew, PhD, Michael Shlipak, MD, MPH, Ronit Katz, DPhil, Sylvia Rosas, MD, MSc, Carmen Peralta, MD, MAS, Mark Woodward, PhD, Holly Kramer, MD, MPH, David Jacobs, PhD, Mark Sarnak, MD, MS, and Josef Coresh, MD, PhD.

Disclosures: The authors reported no financial disclosures.

The article, entitled “Subclinical Atherosclerosis Measures for Cardiovascular Prediction in CKD,” will appear online at http://jasn.asnjournals.org/ on August 21, 2014. The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

Journal of the American Society of Nephrology